Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Nuvectis Pharma Inc (NASDAQ: NVCT) closed at $5.73 down -46.30% from its previous closing price of $10.67. In other words, the price has decreased by -$46.30 from its previous closing price. On the day, 1.71 million shares were traded. NVCT stock price reached its highest trading level at $6.55 during the session, while it also had its lowest trading level at $4.9.
Ratios:
For a deeper understanding of Nuvectis Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.74. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ladenburg Thalmann on July 13, 2022, initiated with a Buy rating and assigned the stock a target price of $21.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 07 ’24 when Carson Michael J. sold 2,755 shares for $8.16 per share. The transaction valued at 22,478 led to the insider holds 87,918 shares of the business.
BENTSUR RON bought 1,940 shares of NVCT for $13,076 on May 14 ’24. The Chairman & CEO now owns 3,246,424 shares after completing the transaction at $6.74 per share. On May 10 ’24, another insider, BENTSUR RON, who serves as the Chairman & CEO of the company, bought 2,000 shares for $6.40 each. As a result, the insider paid 12,800 and bolstered with 3,244,484 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVCT now has a Market Capitalization of 110709328 and an Enterprise Value of 93540176.
Stock Price History:
Over the past 52 weeks, NVCT has reached a high of $12.10, while it has fallen to a 52-week low of $5.85. The 50-Day Moving Average of the stock is -19.89%, while the 200-Day Moving Average is calculated to be -20.59%.
Shares Statistics:
For the past three months, NVCT has traded an average of 142.64K shares per day and 238980 over the past ten days. A total of 17.42M shares are outstanding, with a floating share count of 8.58M. Insiders hold about 55.59% of the company’s shares, while institutions hold 6.24% stake in the company. Shares short for NVCT as of 1730332800 were 1130105 with a Short Ratio of 7.92, compared to 1727654400 on 989582. Therefore, it implies a Short% of Shares Outstanding of 1130105 and a Short% of Float of 11.510000400000001.
